Cited by — Economic impact of abrocitinib monotherapy and combination therapy in patients with moderate-to-severe atopic dermatitis: Results from JADE MONO-2 and JADE COMPARE | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Economic impact of abrocitinib monotherapy and combination therapy in patients with moderate-to-severe atopic dermatitis: Results from JADE MONO-2 and JADE COMPARE.
No admitted local citation edges point to this work yet.
